Target
Egl nine homolog 1 [179-426]
Ligand
BDBM107700
Substrate
n/a
Meas. Tech.
EGLN-1 Activity Assay
IC50
4100±n/a nM
Citation
 Kawamoto, RMWu, SEvdokimov, AGGreis, KDBoyer, ASWarshakoon, NC Prolyl hydroxylase inhibitors and methods of use US Patent  US11426393 Publication Date 8/30/2022 
Target
Name:
Egl nine homolog 1 [179-426]
Synonyms:
C1orf12 | EGLN1 | EGLN1_HUMAN | Hypoxia-inducible factor prolyl hydroxylase 2 (HIFPH2)
Type:
n/a
Mol. Mass.:
27759.84
Organism:
Homo sapiens (Human)
Description:
EGLN-1-179/426
Residue:
248
Sequence:
LRPNGQTKPLPALKLALEYIVPCMNKHGICVVDDFLGKETGQQIGDEVRALHDTGKFTDGQLVSQKSDSSKDIRGDKITWIEGKEPGCETIGLLMSSMDDLIRHCNGKLGSYKINGRTKAMVACYPGNGTGYVRHVDNPNGDGRCVTCIYYLNKDWDAKVSGGILRIFPEGKAQFADIEPKFDRLLFFWSDRRNPHEVQPAYATRYAITVWYFDADERARAKVKYLTGEKGVRVELNKPSDSVGKDVF
  
Inhibitor
Name:
BDBM107700
Synonyms:
US11426393, Compound Table XV.6 | US8598210, Table XV, 6 | US8722895, 6: [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2- carbonyl)-amino]-acetic acid methyl ester | US9598370, Example 00131 | USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)-pyridine-2-carbonyl)-amino]-acetic acid methyl ester
Type:
Small organic molecule
Emp. Form.:
C16H16N2O4
Mol. Mass.:
300.3092
SMILES:
COC(=O)CNC(=O)c1ncc(cc1O)-c1ccc(C)cc1
Structure:
Search PDB for entries with ligand similarity: